Literature DB >> 28539561

Predictors of Mortality, Rehospitalization for Syncope and Cardiovascular Events in Patients With Cardiovascular Syncope.

Tatsuya Onuki1, Makoto Shoji1, Yuya Nakamura1, Ko Ogawa1, Akinori Ochi1, Koichiro Inokuchi1, Shiro Kawasaki1, Yoshimi Onishi1, Yoshimasa Onuma1, Yumi Munetsugu1, Miwa Kikuchi2, Hiroyuki Ito1, Yoshino Minoura1, Norikazu Watanabe1, Taro Adachi1, Mitsuharu Kawamura1, Taku Asano3, Kaoru Tanno2, Youichi Kobayashi1.   

Abstract

BACKGROUND: Predictors of poor outcomes remain unknown for cardiovascular syncope patients after discharge.Methods and 
Results: We reviewed the medical records of consecutive patients admitted to hospital with cardiovascular syncope. We then performed Cox stepwise logistic regression analysis to identify significant independent factors for death, rehospitalization for syncope, and cardiovascular events. The study group was 206 patients with cardiovascular syncope. Of them, bradycardia was diagnosed in 50%, tachycardia in 27%, and structural disease in 23%. During a 1-year follow-up period, 18 (8%) and 45 (23%) patients, respectively, were rehospitalized for syncope or a cardiovascular event, and 10 (4%) died. Independent predictors of cardiovascular events were systolic blood pressure <100 mmHg (odds ratio [OR] 3.25; 95%confidence interval [CI] 1.41-7.51, P=0.006) and implantation of a pacemaker (OR 0.19; 95% CI 0.05-0.51, P=0.0005) (inverse association). Drug-induced syncope (OR 4.57; 95% CI 1.54-12.8, P=0.007) was an independent risk factor for rehospitalization. Finally, a history of congestive heart failure (OR 11.0; 95% CI 2.78-54.7, P=0.0006) and systolic blood pressure <100 mmHg (OR 5.40; 95% CI 1.30-22.7, P=0.02) were identified as significant independent prognostic factors for death.
CONCLUSIONS: Drug-induced syncope, hypotension, no indication for a pacemaker, and a history of congestive heart failure are risk factors post-discharge for patients with cardiovascular syncope and careful follow-up of these patients for at least 1 year is recommended.

Entities:  

Keywords:  Cardiovascular syncope; Outcomes; Predictors

Mesh:

Year:  2017        PMID: 28539561     DOI: 10.1253/circj.CJ-16-1296

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

Review 1.  Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing Platforms.

Authors:  Brian D Guth; Michael Engwall; Sandy Eldridge; C Michael Foley; Liang Guo; Gary Gintant; John Koerner; Stanley T Parish; Jennifer B Pierson; Alexandre J S Ribeiro; Tanja Zabka; Khuram W Chaudhary; Yasunari Kanda; Brian Berridge
Journal:  Front Pharmacol       Date:  2019-08-09       Impact factor: 5.810

2.  Clinical predictors for bradycardia and supraventricular tachycardia necessitating therapy in patients with unexplained syncope monitored by insertable cardiac monitor.

Authors:  Tatsuya Onuki; Makoto Shoji; Hiroto Sugiyama; Shuhei Arai; Kosuke Yoshikawa; Hiroshi Mase; Masaaki Kurata; Miwa Kikuchi; Daisuke Wakatsuki; Taku Asano; Hiroshi Suzuki; Kaoru Tanno; Youichi Kobayashi; Toshiro Shinke
Journal:  Clin Cardiol       Date:  2021-03-16       Impact factor: 2.882

3.  The Impact of a Nurse-Led Syncope Clinic: Experience from a single UK tertiary center.

Authors:  Ahmed M Adlan; Helen Eftekhari; Geeta Paul; Sajad Hayat; Faizel Osman
Journal:  J Arrhythm       Date:  2020-08-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.